Monometl auristatin E intermediate-3 is an intermediate reagent in the synthesis of Monometl auristatin E . Monometl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs).
References:
[1]. Lisa Buckel, et al. Tumor radiosensitization by monometl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.
















